Cargando…
Why judiciously timed anti-IL 6 therapy may be of benefit in severe COVID-19 infection
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198409/ https://www.ncbi.nlm.nih.gov/pubmed/32380318 http://dx.doi.org/10.1016/j.autrev.2020.102563 |